基于指导方针的IDH突变性质瘤治疗后的第一年可靠的认知变化:一个纵向多中心研究

Isabelle Rydén1,2, Francesco Latini3, Åsa Alberius Munkhammar4

  • 1Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Neuro-oncology
|November 9, 2025
PubMed
概括

对异酸脱酶 (IDH) 突变质瘤的多式治疗可以影响认知. 老年和化学放射治疗预测手术后一年的认知能力下降.